How should multimodality imaging be used to evaluate adult patients during and after cancer therapy?
This expert consensus provides a proposed algorithm for multimodality imaging in adult cancer patients, despite the lack of strong clinical data.
administration. We recognize that in the setting of a variety of predisposing factors, varying cumulative dosages of recognized cardiotoxic agents, and use of other agents that are known to increase oxidative stress and compromise myocyte stability, the algorithm proposed in this document cannot be based on strong clinical data.
Plana et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: